- Home
- ACRV vs NTIP Comparison
ACRV vs NTIP Comparison
Compare ACRV & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- NTIP
- Stock Information
- Founded
- ACRV 2018
- NTIP 1990
- Country
- ACRV United States
- NTIP United States
- Employees
- ACRV N/A
- NTIP N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- NTIP Multi-Sector Companies
- Sector
- ACRV Health Care
- NTIP Miscellaneous
- Exchange
- ACRV Nasdaq
- NTIP Nasdaq
- Market Cap
- ACRV 36.1M
- NTIP 31.9M
- IPO Year
- ACRV 2022
- NTIP 1998
- Fundamental
- Price
- ACRV $1.09
- NTIP $1.24
- Analyst Decision
- ACRV Buy
- NTIP
- Analyst Count
- ACRV 7
- NTIP 0
- Target Price
- ACRV $17.60
- NTIP N/A
- AVG Volume (30 Days)
- ACRV 728.6K
- NTIP 6.5K
- Earning Date
- ACRV 05-14-2025
- NTIP 05-09-2025
- Dividend Yield
- ACRV N/A
- NTIP 8.00%
- EPS Growth
- ACRV N/A
- NTIP N/A
- EPS
- ACRV N/A
- NTIP N/A
- Revenue
- ACRV N/A
- NTIP $250,000.00
- Revenue This Year
- ACRV N/A
- NTIP N/A
- Revenue Next Year
- ACRV N/A
- NTIP N/A
- P/E Ratio
- ACRV N/A
- NTIP N/A
- Revenue Growth
- ACRV N/A
- NTIP N/A
- 52 Week Low
- ACRV $1.05
- NTIP $1.17
- 52 Week High
- ACRV $10.16
- NTIP $1.86
- Technical
- Relative Strength Index (RSI)
- ACRV 34.87
- NTIP 47.69
- Support Level
- ACRV $1.06
- NTIP $1.22
- Resistance Level
- ACRV $1.19
- NTIP $1.30
- Average True Range (ATR)
- ACRV 0.09
- NTIP 0.04
- MACD
- ACRV 0.05
- NTIP 0.00
- Stochastic Oscillator
- ACRV 21.57
- NTIP 40.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.